Role of Ayurveda-Virechana karma ,Basti karma and Ayurvedic Medicine in the management of Pre-diabetes

An Open Labelled Randomized Comparative Clinical Trial Between Virechana Karma Followed by Panchatikta Panchaprasrutika Basti and Virechana Karma Followed by Indravati in Pre-Diabetes (Prameha Purvarupa) W.S.R. Homa-IR - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/111140

Enrollment

Registered

2026-05-26

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Willing and able to participate in the study Patient having any of 3 to 4 Prameha Purvarupa which are mentioned in diagnostic criteria Patients Yogya for Virechana Karma and Basti karma as per Ayurvedic classics Pre-diabetes with insulin resistance and who yet to start Medicine HbA1C Value: 5.7percentage to 6.4percentage.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Uncontrolled HTN, Cancer, T.B., Heart disease, Chronic pancreatitis Patient with DM. (FBS more than 126 mg/dL) Patient Ayogya for Virechana Karma and Basti karma Patient diagnosed with type 1 DM Patients on insulin

Design outcomes

Primary

Measure	Time frame
Decrease in Level of HOMA-IRTimepoint: 20-25 days	—

Secondary

Measure	Time frame
An increase in insulin sensitivity leads to enhanced metabolic health by improving glucose control Increase insulin sensitivity help reduce the risk of pre-diabetes progressing to type 2 diabetes and cardiovascular disease. Timepoint: Once after 4 weeks	—

Countries

India

Contacts

Public ContactDr Rita Khagram

Institute of Teaching and Research in Ayurveda

rkhagram@itra.edu.in9998987747

Outcome results